Comparison of a novel fecal marker--fecal tumor pyruvate kinase type M2 (M2-PK) with fecal calprotectin in patients with inflammatory bowel disease: a prospective study.
Shastri
Yogesh M
YM
Centre of Digestive Diseases and Clinical Nutrition, Frankfurt am Main, Germany.
Povse
Nada
N
Schröder
Oliver
O
Stein
Jürgen
J
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000032:analysis; D004797:Enzyme-Linked Immunosorbent Assay; D005243:Feces / Q000737:chemistry / Q000201:enzymology*; D005260:Female; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000175:diagnosis*; D039841:Leukocyte L1 Antigen Complex / Q000032:analysis*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011770:Pyruvate Kinase / Q000032:analysis*; D012680:Sensitivity and Specificity; D055815:Young Adult
D015415:Biomarkers; D039841:Leukocyte L1 Antigen Complex; D011770:Pyruvate Kinase